+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Monitoring & Cardiac Rhythm Management Market (2023-2028) by Products, End-Users, and Geography, Competitive Analysis, Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 182 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5669499
The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is estimated to be USD 45.66 Bn in 2023 and is expected to reach USD 66.23 Bn by 2028, growing at a CAGR of 7.72%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing the risks.

Market Segmentations

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is segmented based on Type, Device, End-User, and Geography.
  • By Type, the market is classified into ECG Devices, Event Monitors, and Smart ECG Monitors.
  • By Device, the market is classified into Defibrillators and Pacemakers.
  • By End-User, the market is classified into Hospitals, Clinics, Cardiac Centres, & Ambulatory Surgery Centres (ASCs) and Other End Users.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, BTL, BPL Medical Technologies, Boston Scientific Corp., Hill Rom Holdings, Inc., ACS Diagnostics, Biotroniketc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cardiac Monitoring & Cardiac Rhythm Management Market

What is the estimated value of the Global Cardiac Monitoring & Cardiac Rhythm Management Market?

The Global Cardiac Monitoring & Cardiac Rhythm Management Market was estimated to be valued at $45.66 Billion in 2023.

What is the growth rate of the Global Cardiac Monitoring & Cardiac Rhythm Management Market?

The growth rate of the Global Cardiac Monitoring & Cardiac Rhythm Management Market is 7.7%, with an estimated value of $66.23 Billion by 2028.

What is the forecasted size of the Global Cardiac Monitoring & Cardiac Rhythm Management Market?

The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be worth $66.23 Billion by 2028.

Who are the key companies in the Global Cardiac Monitoring & Cardiac Rhythm Management Market?

Key companies in the Global Cardiac Monitoring & Cardiac Rhythm Management Market include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Amiitalia, Asahi Kasei Corp., Berlin Hearth, Bexen Cardio, Biotronik, Boston Scientific Corp. and BPL Medical Technologies.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Analyst Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Patients Suffering from Irregular Heart Rate and Rhythm Disorder
4.1.2 Increasing Investments and Expenditure in Healthcare Sector
4.1.3 Significant R&D Contributions from Leading Biotech Firms
4.1.4 Technological Advancements in CM & CRM Techniques
4.2 Restraints
4.2.1 High Cost of CM & CRM Devices
4.2.2 Unfavourable Reimbursement Policies for CM & CRM Devices
4.3 Opportunities
4.3.1 Measures to Reduce Infections Caused due to CIEDs
4.4 Challenges
4.4.1 Stringent Regulatory Requirements Delaying the Approval of Cardiac Devices
4.4.2 Lack of Technical Expertise in Operating Electrocardiography and Cardiac Rhythm Management Devices
4.4.3 Preference for Drugs over Expensive CM & CRM Devices

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTEL Analysis
5.4 SWOT Analysis
5.5 Impact of Covid-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis

6 Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Type
6.1 Introduction
6.2 ECG Devices
6.3 Event Monitors
6.4 Smart ECG Monitors

7 Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Devices
7.1 Introduction
7.2 Defibrillators
7.2.1 Implantable Cardioverter Defibrillators
7.3 Pacemaker
7.3.1 By Implantability
7.3.2 By Type

8 Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End-User
8.1 Introduction
8.2 Hospitals
8.3 Clinics, Cardiac Centres, and Ambulatory Surgery Centres
8.4 Other End Users

9 Americas' Cardiac Monitoring & Cardiac Rhythm Management Devices Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas

10 Europe's Cardiac Monitoring & Cardiac Rhythm Management Devices Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe

11 Middle East and Africa's Cardiac Monitoring & Cardiac Rhythm Management Devices Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA

12 APAC's Cardiac Monitoring & Cardiac Rhythm Management Devices Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements

14 Company Profiles
14.1 Abbott Laboratories
14.2 ACS Diagnostics
14.3 Alivecor, Inc.
14.4 Amiitalia
14.5 Asahi Kasei Corp.
14.6 Berlin Hearth
14.7 Bexen Cardio
14.8 Biotronik
14.9 Boston Scientific Corp.
14.10 BPL Medical Technologies
14.11 BTL
14.12 Cardiac Science Corp. (ZOLL Medical Corporation)
14.13 GE Healthcare
14.14 Hill-Rom Holdings, Inc.
14.15 Jarvik Hearth, Inc.
14.16 Koninklijke Philips N.V.
14.17 Lepu Medical Technology
14.18 LivaNova PLC
14.19 Medtronic PLC
14.20 Metrax GmbH
14.21 Microport Scientific Corp.
14.22 Narang Medical Ltd.
14.23 Nihon Kohden Corp.
14.24 Osypka Ag
14.25 Progetti S.r.l
14.26 Schiller Ag
14.27 Shenzhen Mindray Bio-Medical Electronics
14.28 Shree Pacetronix

15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Amiitalia
  • Asahi Kasei Corp.
  • Berlin Hearth
  • Bexen Cardio
  • Biotronik
  • Boston Scientific Corp.
  • BPL Medical Technologies
  • BTL
  • Cardiac Science Corp. (ZOLL Medical Corp.)
  • GE Healthcare
  • Hill-Rom Holdings, Inc.
  • Jarvik Hearth, Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology
  • LivaNova PLC
  • Medtronic PLC
  • Metrax GmbH
  • Microport Scientific Corp.
  • Narang Medical Ltd.
  • Nihon Kohden Corp.
  • Osypka Ag
  • Progetti S.r.l
  • Schiller Ag
  • Shenzhen Mindray Bio-Medical Electronics
  • Shree Pacetronix